Siga Technologies (SIGA) Operating Margin (2010 - 2025)
Siga Technologies (SIGA) posted Operating Margin of 390.17% for Q3 2025, down 792.89% on a QoQ basis from 56.31% in Q2 2025, and down 39559.0% year-over-year from N/an in Q3 2024.
Siga Technologies (SIGA) Operating Margin (2010 - 2025) Analysis & Trends
Siga Technologies' Operating Margin history runs 16 years deep, the most recent figure standing at 390.17% for Q3 2025.
- Quarterly Operating Margin fell 39559.0% year-over-year to 390.17% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 52.42% (down 778.0% YoY) and the FY2024 annual result came in at 50.45%, down 932.0% from the prior year.
- Operating Margin was 390.17% for Q3 2025 at Siga Technologies, down from 56.31% in the prior quarter.
- Across five years, Operating Margin topped out at 81.51% in Q4 2021 and bottomed at 390.17% in Q3 2025.
- A 5-year average of 13.32% and a median of 0.01% in 2021 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin jumped 12012 bps — and 2025, when it plunged 39559 bps.
- Siga Technologies' Operating Margin stood at 81.51% in 2021, then tumbled by 119 bps to 15.89% in 2022, then jumped by 595 bps to 78.71% in 2023, then retreated by 11 bps to 70.07% in 2024, then plunged by 657 bps to 390.17% in 2025.
- Business Quant data shows SIGA's Operating Margin at 390.17% in Q3 2025, 56.31% in Q2 2025, and 32.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -390.17% |
| Jun 30, 2025 | 56.31% |
| Mar 31, 2025 | -32.03% |
| Dec 31, 2024 | 70.07% |
| Sep 30, 2024 | 5.42% |
| Jun 30, 2024 | 4.95% |
| Mar 31, 2024 | 44.34% |
| Dec 31, 2023 | 78.71% |
| Sep 30, 2023 | -14.18% |
| Jun 30, 2023 | -78.91% |
| Mar 31, 2023 | -25.33% |
| Dec 31, 2022 | -15.89% |
| Sep 30, 2022 | 59.37% |
| Jun 30, 2022 | 18.42% |
| Mar 31, 2022 | -13.65% |
| Dec 31, 2021 | 81.51% |
| Sep 30, 2021 | -60.75% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | -41.33% |
| Dec 31, 2020 | 71.04% |